How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,237 results for

Atrial Septal Defect

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Gore cardioform septal occluder (W.L. Gore &amp Associates) for closure of atrial septal defects

Gore cardioform septal occluder (W.L. Gore & Associates) for closure of atrial septal defects Gore cardioform septal occluder (W.L. Gore & Associates) for closure of atrial septal defects Gore cardioform septal occluder (W.L. Gore & Associates) for closure of atrial septal defects HAYES, Inc Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc. Gore (...) cardioform septal occluder (W.L. Gore & Associates) for closure of atrial septal defects. Lansdale: HAYES, Inc. Healthcare Technology Brief Publication. 2017 Authors' conclusions Health Problem: An atrial septal defect (ASD) is a congenital cardiac anomaly that permits blood flow between the left and right sides of the heart. These defects can range from a few millimeters to 3 centimeters in diameter. ASDs occur in 0.1% of all live births and account for 10% of all congenital heart disease and up to 40

2017 Health Technology Assessment (HTA) Database.

3. Atrial septal defects

Atrial septal defects Atrial septal defects - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Atrial septal defects Last reviewed: February 2019 Last updated: January 2018 Summary There are 4 types of atrial septal defect (ASD): ostium secundum, ostium primum, sinus venosus, and unroofed coronary sinus. Secundum defects are the most common. Most patients are asymptomatic. Untreated defects can produce right atrial (...) . Percutaneous device closure is the preferred treatment for secundum defects, and surgical closure is reserved for larger secundum defects, technically challenging cases, and other defects. If right-to-left shunting (Eisenmenger's syndrome) occurs, the ASD is operable if the shunt is reversible with pulmonary vasodilators. If the shunt is irreversible, the treatment is largely supportive. Definition An atrial septal defect (ASD) is an opening in the atrial septum, excluding a patent foramen ovale. Driscoll

2018 BMJ Best Practice

4. Simultaneous Closure of a Left Atrial Appendage through an Atrial Septal Defect and the Atrial Septal Defect (PubMed)

Simultaneous Closure of a Left Atrial Appendage through an Atrial Septal Defect and the Atrial Septal Defect Left atrial appendage (LAA) occlusion can be employed as an alternative treatment to oral anticoagulation in patients with atrial fibrillation to prevent embolic events. Atrial septal defect (ASD) may be related with right heart dysfunction and allow paradoxical embolism to occur. However, occlusion of both LAA through atrial access with ostium secundum ASD and ASD in the same setting

Full Text available with Trip Pro

2017 Yonsei medical journal

5. Transcatheter atrial septal defect closure in an infant (body weight 6.4 kg) using the GORE CARDIOFORM septal occluder (GCSO) (PubMed)

Transcatheter atrial septal defect closure in an infant (body weight 6.4 kg) using the GORE CARDIOFORM septal occluder (GCSO) Transcatheter closure has become the treatment of choice for secundum atrial septal defects (ASD II), but particularly in small children, there is concern regarding procedure-related complications.We report on a 10-month-old infant, body weight of 6.4 kg, with a large ASD who was referred for failure to thrive and dyspnea on exertion. Echocardiography showed two (...) neighboring ASDs centrally located within an atrial septum with a length of 27 mm resulting in significant left-to-right shunting. During cardiac catheterization, hemodynamic significance of the defect as well as normal pulmonary vascular resistance was demonstrated. Balloon sizing of the central ASD showed a stretched defect diameter of 12 × 11 mm. A 20-mm GORE CARDIOFORM septal occluder (GCSO; Goremedical, W. L. Gore & Associates, Inc., Newark, DE, USA) was implanted without any complications. Initial

Full Text available with Trip Pro

2017 Molecular and cellular pediatrics

6. Feasibility of percutaneous closure of atrial septal defects in adults under transthoracic echocardiography guidance using the Figulla atrial septal defect occluder device (PubMed)

Feasibility of percutaneous closure of atrial septal defects in adults under transthoracic echocardiography guidance using the Figulla atrial septal defect occluder device Closure of atrial septal defect (ASD) among adults under transthoracic echocardiography (TTE) guidance using devices other than the Amplatzer Septal Occluder has not been extensively tested.Assessment of the safety and efficiency of secundum ASD closure using the Occlutech Figulla ASD Occluder under TTE guidance in adult

Full Text available with Trip Pro

2017 Journal of the Saudi Heart Association

7. Transcatheter closure of an atrial septal defect with high risk of erosion using a Figulla Flex II atrial septal defect occluder (PubMed)

Transcatheter closure of an atrial septal defect with high risk of erosion using a Figulla Flex II atrial septal defect occluder An 85-year-old man with a high risk for open heart surgery underwent a percutaneous closure of an atrial septal defect that lacked adequate aortic and superior rims. To avoid the risk for erosion, a Figulla Flex II ASD occluder was selected for the procedure. Implantation was successful, and no complications were observed during the 6 months of follow-up.

Full Text available with Trip Pro

2017 Cardiovascular intervention and therapeutics

8. Interventional Therapy Versus Medical Therapy for Secundum Atrial Septal Defect: A Systematic Review (Part 2) for the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/America

Interventional Therapy Versus Medical Therapy for Secundum Atrial Septal Defect: A Systematic Review (Part 2) for the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/America Secundum atrial septal defect (ASD) is the most common adult congenital heart defect and can present with wide variation in clinical findings. With the intention of preventing morbidity and mortality associated with late presentation of ASD (...) showed a protective effect of ASD closure on New York Heart Association functional class and on right ventricular systolic pressure, volumes, and dimensions. Two additional studies comprising 652 patients were reviewed separately for mortality outcome and primary outcome of interest because they did not meet the inclusion criteria. Those studies showed that ASD closure was associated with a weak protective effect on adjusted mortality rate but no significant impact on atrial arrhythmias in patients

2019 EvidenceUpdates

9. Hybrid muscular ventricular septal defect closure in a 4.5 kg infant followed by sildenafil treatment and transcatheter atrial septal defect occlusion (PubMed)

Hybrid muscular ventricular septal defect closure in a 4.5 kg infant followed by sildenafil treatment and transcatheter atrial septal defect occlusion 29743916 2018 11 14 1734-9338 14 1 2018 Postepy w kardiologii interwencyjnej = Advances in interventional cardiology Postepy Kardiol Interwencyjnej Hybrid muscular ventricular septal defect closure in a 4.5 kg infant followed by sildenafil treatment and transcatheter atrial septal defect occlusion. 112-114 10.5114/aic.2018.74368 Galeczka Michal M (...) Department of Congenital Heart Defects and Pediatric Cardiology, SMDZ in Zabrze, Medical University of Silesia, Silesian Center for Heart Diseases, Zabrze, Poland. Fiszer Roland R Department of Congenital Heart Defects and Pediatric Cardiology, SMDZ in Zabrze, Medical University of Silesia, Silesian Center for Heart Diseases, Zabrze, Poland. Pawlak Szymon S Department of Cardiac, Vascular and Endovascular Surgery and Transplantology, SMDZ in Zabrze, Medical University of Silesia, Silesian Center

Full Text available with Trip Pro

2018 Postępy w kardiologii interwencyjnej = Advances in interventional cardiology

10. Right atrial ball thrombus associated with atrial septal occluder device: A late complication of transcatheter atrial septal defect closure (PubMed)

Right atrial ball thrombus associated with atrial septal occluder device: A late complication of transcatheter atrial septal defect closure 29145231 2018 12 21 2149-2271 18 5 2017 Nov Anatolian journal of cardiology Anatol J Cardiol Right atrial ball thrombus associated with atrial septal occluder device: A late complication of transcatheter atrial septal defect closure. E9 10.14744/AnatolJCardiol.2017.8012 Kalaycı Belma B Department of Cardiology, Faculty of Medicine, Bülent Ecevit University

Full Text available with Trip Pro

2017 Anatolian journal of cardiology

11. Recent advances in managing septal defects: atrial septal defects (PubMed)

Recent advances in managing septal defects: atrial septal defects The purpose of this review is to discuss the management of atrial septal defects (ASD), paying particular attention to the most recent developments. There are four types of ASDs: ostium secundum, ostium primum, sinus venosus, and coronary sinus defects. The fifth type, patent foramen ovale-which is present in 25 to 30% of normal individuals and considered a normal variant, although it may be the seat of paradoxical embolism (...) by surgical or percutaneous approach, as the case may be. Of the four types of ASDs, only the ostium secundum defect is amenable to percutaneous occlusion. For ostium secundum defects, transcatheter closure has been shown to be as effective as surgical closure but with the added benefits of decreased hospital stay, avoidance of a sternotomy, lower cost, and more rapid recovery. There are several FDA-approved devices in use today for percutaneous closure, including the Amplatzer® Septal Occluder (ASO

Full Text available with Trip Pro

2017 F1000Research

12. Atrial ERK1/2 activation in the embryo leads to incomplete Septal closure: a novel mouse model of atrial Septal defect (PubMed)

Atrial ERK1/2 activation in the embryo leads to incomplete Septal closure: a novel mouse model of atrial Septal defect MEK1 mutation and activated MAPK signaling has been found in patients with RASopathies and abnormal cardiac development. Previous studies have suggested that regulation of fetal MAPK signaling is essential for normal cardiac development. We investigated the effect of active MEK1 overexpression on fetal atrial septal development.An inducible double transgenic (DTg) mouse model (...) was developed in which cardiac-specific fetal expression of a constitutively active form of human MEK1 (aMEK1) was induced primarily in the atrium via the withdrawal of doxycycline from the drinking water of pregnant mice. Atrial septal defect (ASD) was found in 51% (23/45) of DTg mice. Fifty-two percent (12/23) of ASD mice died before weaning, and surviving ASD mice exhibited hypertrophic hearts with enlarged right atria and decreased fractional shorting (40 ± 2% vs. 48 ± 0%, p < 0.05). The model mimicked

Full Text available with Trip Pro

2017 Journal of biomedical science

13. Shunt Lesions Part I: Patent Ductus Arteriosus, Atrial Septal Defect, Ventricular Septal Defect, and Atrioventricular Septal Defect. (PubMed)

Shunt Lesions Part I: Patent Ductus Arteriosus, Atrial Septal Defect, Ventricular Septal Defect, and Atrioventricular Septal Defect. This review summarizes the current understanding of the pathophysiology and perioperative management of patent ductus arteriosus, atrial septal defect, ventricular septal defect, and atrioventricular septal defect.MEDLINE and PubMed.The four congenital cardiac lesions that are the subject of this review, patent ductus arteriosus, atrial septal defect, ventricular (...) septal defect, and atrioventricular septal defect, are the most commonly found defects causing a left-to-right shunt. These defects frequently warrant transcatheter or surgical intervention. Although the perioperative care is relatively straightforward for many of these patients, there are a number of management strategies and complications associated with each intervention. The treatment outcomes for all of these lesions are very good in the current era.

2016 Pediatric Critical Care Medicine

14. Standard median sternotomy, right minithoracotomy, totally thoracoscopic surgery, percutaneous closure, and transthoracic closure for atrial septal defects in children: a network meta-analysis

Standard median sternotomy, right minithoracotomy, totally thoracoscopic surgery, percutaneous closure, and transthoracic closure for atrial septal defects in children: a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

15. Incidence and predictors of iatrogenic atrial septal defects following the mitraclip procedure: a systematic review and meta-analysis

Incidence and predictors of iatrogenic atrial septal defects following the mitraclip procedure: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

16. EDUCATIONAL SERIES IN CONGENITAL HEART DISEASE: Echocardiographic assessment of left to right shunts: atrial septal defect, ventricular septal defect, atrioventricular septal defect, patent arterial duct (PubMed)

EDUCATIONAL SERIES IN CONGENITAL HEART DISEASE: Echocardiographic assessment of left to right shunts: atrial septal defect, ventricular septal defect, atrioventricular septal defect, patent arterial duct This review article will guide the reader through the basics of echocardiographic assessment of congenital left to right shunts in both paediatric and adult age groups. After reading this article, the reader will understand the pathology and clinical presentation of atrial septal defects (ASDs (...) ), ventricular septal defects (VSDs), atrioventricular septal defects (AVSDs) and patent arterial duct. Echocardiography is the mainstay in diagnosis and follow-up assessment of patients with congenital heart disease. This article will therefore describe the echocardiographic appearances of each lesion, and point the reader towards specific features to look for echocardiographically.© 2018 The authors.

Full Text available with Trip Pro

2018 Echo research and practice

17. Iatrogenic atrial septal defect with right-to-left shunt following atrial fibrillation ablation in a patient with arrhythmogenic right ventricular cardiomyopathy (PubMed)

Iatrogenic atrial septal defect with right-to-left shunt following atrial fibrillation ablation in a patient with arrhythmogenic right ventricular cardiomyopathy 29755946 2019 02 26 2214-0271 4 4 2018 Apr HeartRhythm case reports HeartRhythm Case Rep Iatrogenic atrial septal defect with right-to-left shunt following atrial fibrillation ablation in a patient with arrhythmogenic right ventricular cardiomyopathy. 159-162 10.1016/j.hrcr.2017.11.013 Lee Adam A Section of Cardiac Electrophysiology (...) States HeartRhythm Case Rep 101656239 2214-0271 Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular dysplasia Atrial fibrillation Atrial septal defect Cyanosis Pulmonary vein isolation Right-to-left shunt Transseptal puncture 2018 5 15 6 0 2018 5 15 6 0 2018 5 15 6 1 epublish 29755946 10.1016/j.hrcr.2017.11.013 S2214-0271(17)30203-8 PMC5944033 Circ Arrhythm Electrophysiol. 2011 Apr;4(2):166-71 21248245 Am Heart J. 1988 Jan;115(1 Pt 1):201-3 3336980 JACC Cardiovasc Interv

Full Text available with Trip Pro

2018 HeartRhythm Case Reports

18. Left atrial pressure is associated with iatrogenic atrial septal defect after mitral valve clip. (PubMed)

Left atrial pressure is associated with iatrogenic atrial septal defect after mitral valve clip. Mitral valve (MV) clip procedure requires interatrial trans-septal puncture to access the left atrium (LA). Iatrogenic atrial septal defect (iASD) is not uncommon and may remain for a while. However, haemodynamic and echocardiographic determinants of persistent iASD are not well investigated. We sought to find haemodynamic and echocardiographic determinants of iASD after MV clip.A total of 131

2018 Heart

19. Atrial septal defect closure in adulthood is associated with normal survival in the mid to longer term. (PubMed)

Atrial septal defect closure in adulthood is associated with normal survival in the mid to longer term. The prognostic benefit of atrial septal defect (ASD) closure in adulthood, particularly in advanced age, remains uncertain. The aim of our study was to examine the impact of ASD closure in a contemporary adult cohort on mid to longer term survival as compared with expected survival in the general population.We study herewith all consecutive patients (≥16 years of age) who underwent ASD

2019 Heart

20. Embolization of high-output idiopathic renal arteriovenous fistula primarily using an atrial septal defect occluder via venous access: a case report. (PubMed)

Embolization of high-output idiopathic renal arteriovenous fistula primarily using an atrial septal defect occluder via venous access: a case report. The case report is to evaluate the efficacy and safety of embolization of a high-output idiopathic renal arteriovenous fistula (IRAVF) with an atrial septal defect occluder (ASDO) via venous access.A 57-year-old male diagnosed with high-output IRAVF received embolization with an ASDO via renal venous access and compact occlusion with 3 vascular

Full Text available with Trip Pro

2019 BMC Nephrology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>